Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wiem Ben Ayed"'
Autor:
Fadila Amraoui, Wiem Ben Ayed, Yoann Madec, Chafika Faraj, Oumnia Himmi, Ameur Btissam, Mhammed Sarih, Anna-Bella Failloux
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 2, p e0006997 (2019)
In 2015, the mosquito Aedes albopictus was detected in Rabat, Morocco. This invasive species can be involved in the transmission of more than 25 arboviruses. It is known that each combination of mosquito population and virus genotype leads to a speci
Externí odkaz:
https://doaj.org/article/995ac3f501c34269b128ebcd250583df
Autor:
Imen Toukabri, Azza Ben Said, Adel Hamdi, Aziza Aloulou, Wiem Ben Ayed, Ines Cherif, Imen Limayem
Publikováno v:
Journal of Oncology Pharmacy Practice. 29:613-618
Introduction Cardiotoxicity is the most important side effect of Trastuzumab treatment. The purpose of this study is to evaluate the prevalence of Trastuzumab induced cardiotoxicity and to analyze risk factors associated with this side effect. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64552c478248258825f6c4d1cf5ea2d2
https://doi.org/10.1177/10781552221076407
https://doi.org/10.1177/10781552221076407
Autor:
Azza Gabsi, Amina Mokrani, Imen Toukabri, Adel Hamdi, Imen Limayem, Wiem Ben Ayed, Karawen Tounsi, Azza Ben Said
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:1948-1957
Introduction The use of complementary and alternative medicine (CAM) among cancer patients is prevalent worldwide as cancer patient are perpetually seeking for a way to improve their quality of life and to cure their disease. Unfortunately, the major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2eb3d6eb808af2e4afba0057ee4bce3
https://doi.org/10.1177/1078155220980131
https://doi.org/10.1177/1078155220980131
Autor:
Myriam Razgallah Khrouf, Chema Drira, Mohamed Ali Soussi, Wiem Ben Ayed, Hanen Ouesleti, Ines Fradi, Fathi Safta, Besma Hamdene
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:827-833
Background Cytarabine is widely used to treat leukemia and lymphoma. Currently, Cyrabol®, powder for injection, is one of the specialties marketed in Tunisia. However, no stability data when diluted with 0.9% NaCl are available. The aim of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a16efa78d64fce87dd9b4be5a3ef57
https://doi.org/10.1177/1078155220937405
https://doi.org/10.1177/1078155220937405
Autor:
Imen Toukabri Ben Mahmoud, Azza Ben Said, Souad Berguiga, Racha Houij, Ines Cherif, Adel Hamdi, Wiem Ben Ayed, Imen Limayem
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction Oxaliplatin utilized in colorectal neoplasms treatment could induce acute peripheral neuropathy (APN) which is a dreadful and frequent adverse event. The objective of this study is to estimate incidence of APN induced by oxaliplatin cumu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a28df57736d8bd60cceb0b821d7e05
https://pubmed.ncbi.nlm.nih.gov/34918549
https://pubmed.ncbi.nlm.nih.gov/34918549